Your comments are important to us.
Your feedback is used to help design future educational programs.

1. Are you a cancer survivor (a survivor is anyone diagnosed with cancer)? Yes       No  If you are not a cancer survivor, what is your relationship? Caregiver  Spouse  Parent  Other relative  Friend  Professional If you are a healthcare professional, please indicate your degree and place of work:(255 char. max)  Degree (eg, RN, MD, MSW):    Place of work (eg, hospital, community clinic, private practice, etc.):     2. What is your age? under 18   18 to 25   26 to 30   31 to 40   41 to 50   51 to 60 61 to 70   71 or older   3. What is your gender? Male         Female   4. If you are a cancer survivor, how long has it been since you were diagnosed? N/A    Less than 30 days   1–3 months   4–7 months   8–11 months 1–3 years   4–7 years   8–10 years   11–20 years   More than 20 years   5. What treatments have been used? Stem Cell Transplant Chemotherapy Oral Therapies:(255 char. max) Other:(255 char. max)   6. Are you (or the survivor) currently in, currently considering, or have participated in a clinical trial? Currently in a clinical trial Considering participation in a clinical trial Have participated in a clinical trial No N/A   7. Have you (or the survivor) discussed a clinical trial with your (or the survivor’s) physician? Yes       No      N/A   8. Please give us your feedback on the presentations. Select 1 answer for each. Presentation Poor Fair Satisfactory Good Excellent Program Overall What's New for Newly Diagnosed Patients – Brian J. Druker, MD What's New for Relapsed/Refractory Patients – Neil P. Shah, MD, PhD Panel Discussion – Brian J. Druker, MD and Neil P. Shah, MD, PhD   9. If you had access to this information at the time of diagnosis or during treatment, would it have changed the way you managed your (or the survivor’s) disease? Yes       No      N/A If so, how? (255 char. max)   10. Having completed this program, do you feel more prepared to discuss your (or the survivor's) treatment management plan with your/their healthcare team? Yes       No      N/A If so, how? (255 char. max)   11. Do you feel this program will help you (or the survivor) cope with the challenges related to the disease? Yes       No     N/A If so, how? (255 char. max)   12. Overall, how helpful was this program? Not helpful at all      Somewhat helpful      Helpful      Very helpful   13. What can we do to improve this program? (255 char. max)   14. How did you hear about this program? Direct mail (eg, announcement) Email LLS Web site LLS chapter representative Colleague Booth at professional meeting Other:(255 char. max)   15. Other comments: (255 char. max) Thank you for your feedback.